Molecular Templates Inc (NASDAQ:MTEM) has a beta value of 1.13 and has seen 2.58 million shares traded in the recent trading session. The company, currently valued at $2.11M, closed the recent trade at $0.32 per share which meant it lost -$1.15 on the day or -78.23% during that session. The MTEM stock price is -2040.62% off its 52-week high price of $6.85 and -212.5% below the 52-week low of $1.00. If we look at the company’s 10-day average daily trading volume, we find that it stood at 22270.0 shares traded. The 3-month trading volume is 61.47K shares.
Molecular Templates Inc (NASDAQ:MTEM) trade information
Sporting -78.23% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the MTEM stock price touched $0.32 or saw a rise of 78.38%. Year-to-date, Molecular Templates Inc shares have moved -91.42%, while the 5-day performance has seen it change -77.78%. Over the past 30 days, the shares of Molecular Templates Inc (NASDAQ:MTEM) have changed -73.11%. Short interest in the company has seen 0.14 million shares shorted with days to cover at 3.02.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Molecular Templates Inc (MTEM) estimates and forecasts
The company’s shares have lost -82.02% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -78.50%.
1 analysts offering their estimates for the company have set an average revenue estimate of 330k for the current quarter. 1 have an estimated revenue figure of 340k for the next ending quarter. Year-ago sales stood 6.8M and 7.02M respectively for this quarter and the next, and analysts expect sales will shrink by -95.10% for the current quarter and -78.50% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 34.83% over the past 5 years. Earnings growth for 2024 is a modest -62.78% while over the next 5 years, the company’s earnings are expected to increase by 3.20%.
MTEM Dividends
Molecular Templates Inc is expected to release its next earnings report on 2024-Nov-11 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Molecular Templates Inc (NASDAQ:MTEM)’s Major holders
Insiders own 3.96% of the company shares, while shares held by institutions stand at 56.12% with a share float percentage of 58.43%. Investors are also buoyed by the number of investors in a company, with Molecular Templates Inc having a total of 33.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . As of Jun 30, 2024 , the former fund manager holds about 0.76% shares in the company for having 49.89 shares of worth $15959.0 while later fund manager owns 27.86 shares of worth $8912.0 as of Aug 31, 2024 , which makes it owner of about 0.42% of company’s outstanding stock.
